Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized double-blind placebo-controlled 2-week crossover knemometric study of GW685698X in allergic rhinitis
2004-004749-17Phase 3Completed
- Sponsor
- GSK
- Start
- Jul 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fluticasone propionate in seasonal allergic rhinitis (SAR) and perennial rhinitis (2 arms), sponsored by GSK. Primary endpoint: Lower leg growth velocity. Started Jul 2008; status: completed.
02
Drugs
fluticasone propionate
03
Conditions
seasonal allergic rhinitis (SAR)perennial rhinitis
Beyond the preview
Go deeper on 2004-004749-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004749-17.